Pathogenesis and Management of Acquired Haemophilia.

about

Acquired haemophilia in recipients of depot thioxanthenes.

P2860

Q45873341-67690810-C50C-4C1B-9491-F030463BDCC4

P2860

Pathogenesis and Management of Acquired Haemophilia.

Item

http://www.wikidata.org/entity/Q45856316

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Pathogenesis and Management of Acquired Haemophilia.

@en

Pathogenesis and Management of Acquired Haemophilia.

@nl

type

Item

label

Pathogenesis and Management of Acquired Haemophilia.

@en

Pathogenesis and Management of Acquired Haemophilia.

@nl

prefLabel

Pathogenesis and Management of Acquired Haemophilia.

@en

Pathogenesis and Management of Acquired Haemophilia.

@nl

P1476

Pathogenesis and Management of Acquired Haemophilia.

@en

P2093

A J Stewart

http://www.w3.org/2001/XMLSchema#string

C A Ludlam

http://www.w3.org/2001/XMLSchema#string

J M Saint-Remy

http://www.w3.org/2001/XMLSchema#string

P2860

Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.

Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.

Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy

Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor

Acquired inhibitors in malignant and nonmalignant disease states.

Acquired haemophilia: an important but often unrecognised cause of bleeding in elderly people.

The cellular basis of T-cell memory.

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.

Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease.

DDAVP in acquired hemophilia A: case report and review of the literature.

P304

181-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.1998.11746390

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27416527

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

Pathogenesis and Management of Acquired Haemophilia.

about

P2860

P2860

Pathogenesis and Management of Acquired Haemophilia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921